Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups

Arthritis Rheumatol. 2023 Aug;75(8):1325-1327. doi: 10.1002/art.42520. Epub 2023 May 24.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Antirheumatic Agents*
  • Biosimilar Pharmaceuticals*
  • Double-Blind Method
  • Hiccup*
  • Humans

Substances

  • Adalimumab
  • Biosimilar Pharmaceuticals
  • Antirheumatic Agents